Abstract Details

Title The Adult Spasticity International Registry (ASPIRE) Study: Real-World Treatment Utilization and Effectiveness of OnabotulinumtoxinA in Post-Stroke Patients Treated for Spasticity

Topic Movement Disorders

Presentation(s) P5 - (-)

Poster/Presentation
Number 048

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
	No disclosure on file
Daniel Bandari, MD (MS Center of California)	No disclosure on file
Wolfgang Jost	No disclosure on file
Aleksej Zuzek, PhD (Allergan)	Dr. Zuzek has received personal compensation for serving as an employee of AbbVie Inc.. Dr. Zuzek has stock in AbbVie Inc..
	No disclosure on file
Alberto Esquenazi, MD (Department of Physical Medicine and Rehabilitation)	Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen and Allergan. Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen and Allergan. The institution of Dr. Esquenazi has received research support from Ipsen, Allergan and Merz.